Location History:
- Kawanishi, JA (1976 - 1977)
- Toyonaka, JA (1976 - 1977)
- Osaka, JA (1977)
- Kawanishi, JP (1978 - 1979)
Company Filing History:
Years Active: 1976-1979
Title: Akio Izawa: Pioneer in Cephalosporin Derivatives
Introduction
Akio Izawa is a prolific inventor based in Toyonaka, Japan, known for his exceptional contributions to the pharmaceutical field. With a total of 12 patents to his name, Izawa has made significant strides in the development of antimicrobial agents, particularly cephalosporin derivatives.
Latest Patents
Among his latest innovations, Izawa has developed a cephalosporin derivative characterized as N-acylamino-.alpha.-arylacetamido cephalosporins. This compound is distinguished by a unique formula wherein A represents a mono- or polycyclic heteroaromatic ring containing at least one nitrogen atom as a hetero atom, which may be substituted with various substituents. The R group is a substituted phenyl group featuring at least one of the following substituents: an amino group, a hydroxy group, a ureido group, or a hydroxymethyl group. The X group is either an --OCOCH.sub.3 group or an --S-Het group, where Het indicates a 5- or 6-membered heterocyclic ring that includes one to four hetero atoms—namely nitrogen, oxygen, and sulfur—which can also have multiple substituents. These compounds are not only innovative but also beneficial as antimicrobial agents, developed through specific chemical reactions involving a compound of the formula (II).
Career Highlights
Izawa is affiliated with Sumitomo Chemical Company, Limited, where he continues to engage in groundbreaking research and development in the field of pharmaceuticals. His work not only enhances the product line of the company but also contributes to advancements in medical treatment options.
Collaborations
Throughout his career, Akio Izawa has worked closely with several distinguished colleagues, including Takenari Nakagome and Toshiaki Komatsu. This collaborative effort has been instrumental in advancing their shared research goals and expanding their collective expertise in medicinal chemistry.
Conclusion
In summary, Akio Izawa stands out as a key inventor in the realm of cephalosporin derivatives, with his innovative approach leading to the creation of valuable antimicrobial compounds. His achievements at Sumitomo Chemical Company illustrate the impactful contribution of inventors in the pharmaceutical industry, fostering ongoing improvements in healthcare solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.